My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 144

    1.

    Diabetic nephropathy: hemodynamic basis and implications for disease management.

    Noth RH, Krolewski AS, Kaysen GA, Meyer TW, Schambelan M.

    Ann Intern Med. 1989 May 15;110(10):795-813. Review.PMID: 2653154 [PubMed - indexed for MEDLINE]Related articles

    2.

    [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]

    Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.

    Presse Med. 2002 Nov 9;31(36):1714-20. Review. French. PMID: 12467154 [PubMed - indexed for MEDLINE]Related articles

    3.

    Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points.

    Parving HH, Andersen S, Jacobsen P, Christensen PK, Rossing K, Hovind P, Rossing P, Tarnow L.

    Semin Nephrol. 2004 Mar;24(2):147-57. Review.PMID: 15017527 [PubMed - indexed for MEDLINE]Related articles

    4.

    Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.

    Mogensen CE.

    J Intern Med. 2003 Jul;254(1):45-66. Review.PMID: 12823642 [PubMed - indexed for MEDLINE]Related articles

    5.

    Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.

    Ruilope LM, Segura J.

    Clin Ther. 2003 Dec;25(12):3044-64. Review.PMID: 14749145 [PubMed - indexed for MEDLINE]Related articles

    6.

    Systematic review on urine albumin testing for early detection of diabetic complications.

    Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

    Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.PMID: 16095545 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Treatment of diabetic nephropathy with angiotensin II receptor antagonist.

    Lewis EJ, Lewis JB.

    Clin Exp Nephrol. 2003 Mar;7(1):1-8. Review.PMID: 14586737 [PubMed - indexed for MEDLINE]Related articles

    8.

    Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.

    Jacobsen P, Rossing K, Parving HH.

    Curr Opin Nephrol Hypertens. 2004 May;13(3):319-24. Review.PMID: 15073491 [PubMed - indexed for MEDLINE]Related articles

    9.

    Renal protection and antihypertensive drugs: current status.

    Salvetti A, Mattei P, Sudano I.

    Drugs. 1999 May;57(5):665-93. Review.PMID: 10353294 [PubMed - indexed for MEDLINE]Related articles

    10.

    The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.

    Zanella MT, Ribeiro AB.

    Clin Ther. 2002 Jul;24(7):1019-34. Review.PMID: 12182249 [PubMed - indexed for MEDLINE]Related articles

    11.

    Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

    Thomas MC, Atkins RC.

    Drugs. 2006;66(17):2213-34. Review.PMID: 17137404 [PubMed - indexed for MEDLINE]Related articles

    12.

    Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?

    Vogt L, Kocks MJ, Laverman GD, Navis G.

    Minerva Med. 2004 Oct;95(5):395-409. Review.PMID: 15467515 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Current concepts of renal hemodynamics in diabetes.

    Anderson S, Vora JP.

    J Diabetes Complications. 1995 Oct-Dec;9(4):304-7. Review.PMID: 8573753 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prevention of loss of renal function over time in patients with diabetic nephropathy.

    Barnett A.

    Am J Med. 2006 May;119(5 Suppl 1):S40-7. Review.PMID: 16563947 [PubMed - indexed for MEDLINE]Related articles

    15.

    Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?

    Castellino P, Shohat J, DeFronzo RA.

    Semin Nephrol. 1990 May;10(3):228-41. Review.PMID: 2190280 [PubMed - indexed for MEDLINE]Related articles

    16.

    Losartan in diabetic nephropathy.

    Perico N, Ruggenenti P, Remuzzi G.

    Expert Rev Cardiovasc Ther. 2004 Jul;2(4):473-83. Review.PMID: 15225108 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy.

    Bretzel RG.

    J Diabetes Complications. 1997 Mar-Apr;11(2):112-22. Review.PMID: 9101397 [PubMed - indexed for MEDLINE]Related articles

    18.

    Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.

    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.

    Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):129-38.PMID: 15835375 [PubMed - indexed for MEDLINE]Related articles

    19.

    Renal protection in hypertensive patients: selection of antihypertensive therapy.

    Wenzel RR.

    Drugs. 2005;65 Suppl 2:29-39. Review.PMID: 16398060 [PubMed - indexed for MEDLINE]Related articles

    20.

    Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.

    Parving HH.

    J Hypertens Suppl. 1998 Jan;16(1):S99-101. Review.PMID: 9534107 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity